Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 May, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 531162 | NSE: EMAMILTD

Emami Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 13, 2025, 12:40 am

Market Cap 27,661 Cr.
Current Price 634
High / Low 860/467
Stock P/E35.1
Book Value 60.2
Dividend Yield1.26 %
ROCE31.7 %
ROE30.0 %
Face Value 1.00
PEG Ratio2.88

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Emami Ltd

Competitors of Emami Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Honasa Consumer Ltd 8,088 Cr. 248 547/190119 35.50.00 %17.1 %% 10.0
Ambica Agarbathies Aroma & Industries Ltd 47.3 Cr. 27.4 37.0/23.217.9 60.60.00 %5.07 %3.65 % 10.0
Ador Multi Products Ltd 33.6 Cr. 72.0 84.0/23.4 23.20.00 %33.6 %26.7 % 10.0
Kaya Ltd 336 Cr. 257 702/204 1060.00 %80.4 %% 10.0
Jyothy Labs Ltd 12,903 Cr. 351 596/26834.5 55.81.00 %25.1 %19.4 % 1.00
Industry Average72,116.64 Cr1,979.7350.48109.470.76%36.03%26.00%4.94

All Competitor Stocks of Emami Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 9717707738149838368268659968919068911,049
Expenses 633612604621689636636632682682692645715
Operating Profit 338158169193294199190233314209214246334
OPM % 35%21%22%24%30%24%23%27%32%24%24%28%32%
Other Income 17256427148111111102215
Interest 2222212233222
Depreciation 84838848476446464648444546
Profit before tax 2699885186251148150196276169178220301
Tax % 18%-262%14%3%7%4%9%8%6%13%16%4%7%
Net Profit 22035473180233142137180261147151211279
EPS in Rs 4.958.071.674.175.383.273.144.095.923.413.504.876.39

Last Updated: March 3, 2025, 4:38 pm

Below is a detailed analysis of the quarterly data for Emami Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is 1,049.00 Cr.. The value appears strong and on an upward trend. It has increased from 891.00 Cr. (Sep 2024) to 1,049.00 Cr., marking an increase of 158.00 Cr..
  • For Expenses, as of Dec 2024, the value is 715.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 645.00 Cr. (Sep 2024) to 715.00 Cr., marking an increase of 70.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is 334.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Sep 2024) to 334.00 Cr., marking an increase of 88.00 Cr..
  • For OPM %, as of Dec 2024, the value is 32.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Sep 2024) to 32.00%, marking an increase of 4.00%.
  • For Other Income, as of Dec 2024, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Sep 2024) to 15.00 Cr., marking a decrease of 7.00 Cr..
  • For Interest, as of Dec 2024, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
  • For Depreciation, as of Dec 2024, the value is 46.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 45.00 Cr. (Sep 2024) to 46.00 Cr., marking an increase of 1.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is 301.00 Cr.. The value appears strong and on an upward trend. It has increased from 220.00 Cr. (Sep 2024) to 301.00 Cr., marking an increase of 81.00 Cr..
  • For Tax %, as of Dec 2024, the value is 7.00%. The value appears to be increasing, which may not be favorable. It has increased from 4.00% (Sep 2024) to 7.00%, marking an increase of 3.00%.
  • For Net Profit, as of Dec 2024, the value is 279.00 Cr.. The value appears strong and on an upward trend. It has increased from 211.00 Cr. (Sep 2024) to 279.00 Cr., marking an increase of 68.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 6.39. The value appears strong and on an upward trend. It has increased from 4.87 (Sep 2024) to 6.39, marking an increase of 1.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:24 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 1,5951,7002,0762,3582,4882,5312,6952,6552,8813,1923,4063,5783,737
Expenses 1,2521,2551,5361,6701,7291,8121,9701,9702,0002,2542,5502,6322,734
Operating Profit 3434455416887597197256858809388559461,004
OPM % 22%26%26%29%31%28%27%26%31%29%25%26%27%
Other Income 54539144311925466990694158
Interest 75554583421211357109
Depreciation 223534255309311325336367335247186183
Profit before tax 369457592423424393403374569688670791869
Tax % 15%12%18%14%20%22%25%19%20%-22%6%8%
Net Profit 315402485363340306303302455837627724787
EPS in Rs 6.938.8710.708.007.506.776.686.6710.2319.0214.5016.5818.17
Dividend Payout % 38%39%33%44%47%52%60%60%78%42%55%48%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)27.62%20.65%-25.15%-6.34%-10.00%-0.98%-0.33%50.66%83.96%-25.09%15.47%
Change in YoY Net Profit Growth (%)0.00%-6.97%-45.80%18.82%-3.66%9.02%0.65%50.99%33.29%-109.05%40.56%

Emami Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:8%
5 Years:6%
3 Years:8%
TTM:6%
Compounded Profit Growth
10 Years:6%
5 Years:19%
3 Years:18%
TTM:9%
Stock Price CAGR
10 Years:2%
5 Years:28%
3 Years:14%
1 Year:22%
Return on Equity
10 Years:27%
5 Years:28%
3 Years:33%
Last Year:30%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 12:35 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 15232323232345454444444444
Reserves 7629091,2081,5891,7321,9912,0311,7781,7182,0322,2592,4032,585
Borrowings 1153836671473326110210101282919474
Other Liabilities 324333410409376458633644656692703728891
Total Liabilities 1,2161,3021,6762,6922,6032,7982,8192,6782,5203,0503,0963,2693,594
Fixed Assets 3973964531,9181,9941,8021,6801,4591,1321,3441,2451,1141,039
CWIP 47122967223036863689
Investments 163296501104128314187156255303293442624
Other Assets 6095996936044606529151,0551,1261,4001,5511,7061,922
Total Assets 1,2161,3021,6762,6922,6032,7982,8192,6782,5203,0503,0963,2693,594

Below is a detailed analysis of the balance sheet data for Emami Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 44.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹2,585.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,403.00 Cr. (Mar 2024) to ₹2,585.00 Cr., marking an increase of 182.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹74.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 94.00 Cr. (Mar 2024) to ₹74.00 Cr., marking a decrease of 20.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹891.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 728.00 Cr. (Mar 2024) to ₹891.00 Cr., marking an increase of 163.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹3,594.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,269.00 Cr. (Mar 2024) to ₹3,594.00 Cr., marking an increase of 325.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹1,039.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,114.00 Cr. (Mar 2024) to ₹1,039.00 Cr., marking a decrease of 75.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to ₹9.00 Cr., marking an increase of 1.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹624.00 Cr.. The value appears strong and on an upward trend. It has increased from 442.00 Cr. (Mar 2024) to ₹624.00 Cr., marking an increase of 182.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹1,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,706.00 Cr. (Mar 2024) to ₹1,922.00 Cr., marking an increase of 216.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹3,594.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,269.00 Cr. (Mar 2024) to ₹3,594.00 Cr., marking an increase of 325.00 Cr..

Notably, the Reserves (2,585.00 Cr.) exceed the Borrowings (74.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +323428534562730588554531922644749779
Cash from Investing Activity +-130-140-237-1,313-306-276-26-231-224-234-122-210
Cash from Financing Activity +-188-301-215502-496-324-428-405-688-402-608-563
Net Cash Flow5-1382-249-72-12100-10698196

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow228.00407.00505.0017.00286.00393.00615.00475.00779.00656.00764.00852.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days261718201422294229374450
Inventory Days58765968838788102118121100102
Days Payable52779011285109115135138138126143
Cash Conversion Cycle3216-13-24121291019189
Working Capital Days-7-6-133-37159369313755
ROCE %42%50%61%30%23%22%19%18%29%31%28%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters53.86%53.86%54.27%54.27%54.27%54.27%54.27%54.52%54.84%54.84%54.84%54.84%
FIIs12.71%12.52%12.72%11.47%11.25%11.14%11.01%11.46%11.90%12.86%13.46%14.02%
DIIs24.17%25.49%24.32%26.47%27.02%27.02%26.92%26.22%25.21%23.94%22.06%21.61%
Public9.26%8.14%8.69%7.80%7.47%7.58%7.81%7.81%8.05%8.35%9.63%9.53%
No. of Shareholders82,19383,25786,24289,97185,46090,28597,04389,95579,21682,15191,33497,258

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Emerging Equity Fund - Regular Plan8,135,3751.13508.878,135,3752025-04-22 17:25:360%
HDFC Mid-Cap Opportunities Fund - Regular Plan7,419,4850.71464.097,419,4852025-04-22 13:31:130%
Nippon India Small Cap Fund7,360,2520.89460.387,360,2522025-04-22 17:25:360%
SBI Large & Midcap Fund6,500,0001.73406.586,500,0002025-04-22 15:56:580%
DSP Mid Cap Fund5,265,7421.86329.375,265,7422025-04-22 15:56:580%
DSP ELSS Tax Saver Fund4,224,3691.74264.234,224,3692025-04-22 17:25:360%
Franklin India Prima Fund3,676,2252.09229.953,676,2252025-04-22 15:56:580%
HDFC Small Cap Fund - Regular Plan3,365,8920.72210.543,365,8922025-04-22 15:56:580%
DSP Equity Opportunities Fund2,906,6501.52181.812,906,6502025-04-22 17:25:360%
Franklin India Smaller Companies Fund2,750,0001.34172.012,750,0002025-04-22 02:06:430%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 16.5514.5018.8810.236.67
Diluted EPS (Rs.) 16.5514.5018.8810.236.67
Cash EPS (Rs.) 20.9320.0026.8818.5814.23
Book Value[Excl.RevalReserv]/Share (Rs.) 56.3052.4347.0239.6340.22
Book Value[Incl.RevalReserv]/Share (Rs.) 56.3052.4347.0239.6340.22
Revenue From Operations / Share (Rs.) 81.9777.2072.3664.8058.58
PBDIT / Share (Rs.) 22.8321.1223.7521.4516.50
PBIT / Share (Rs.) 18.5715.5116.1613.199.08
PBT / Share (Rs.) 18.2015.3515.9312.898.38
Net Profit / Share (Rs.) 16.6714.3919.3010.326.80
NP After MI And SOA / Share (Rs.) 16.5814.5019.0210.236.68
PBDIT Margin (%) 27.8427.3532.8133.0928.16
PBIT Margin (%) 22.6420.0922.3320.3515.49
PBT Margin (%) 22.2019.8722.0119.8914.29
Net Profit Margin (%) 20.3418.6426.6615.9311.61
NP After MI And SOA Margin (%) 20.2218.7726.2815.7811.40
Return on Networth / Equity (%) 29.5727.7740.4025.7916.60
Return on Capital Employeed (%) 32.1428.6833.2832.2221.80
Return On Assets (%) 22.0620.5627.4418.0411.30
Total Debt / Equity (X) 0.020.030.120.050.11
Asset Turnover Ratio (%) 1.121.001.071.040.90
Current Ratio (X) 1.871.781.171.611.30
Quick Ratio (X) 1.441.320.781.180.99
Inventory Turnover Ratio (X) 2.362.432.722.653.17
Dividend Payout Ratio (NP) (%) 48.2655.1842.3878.20119.88
Dividend Payout Ratio (CP) (%) 38.3939.7930.2943.2756.80
Earning Retention Ratio (%) 51.7444.8257.6221.80-19.88
Cash Earning Retention Ratio (%) 61.6160.2169.7156.7343.20
Interest Coverage Ratio (X) 99.86126.05206.5171.8335.58
Interest Coverage Ratio (Post Tax) (X) 74.5486.90169.8335.5816.18
Enterprise Value (Cr.) 18339.380.0019900.1021407.377794.39
EV / Net Operating Revenue (X) 5.130.006.237.432.94
EV / EBITDA (X) 18.410.0019.0022.4610.43
MarketCap / Net Operating Revenue (X) 5.160.006.197.532.90
Retention Ratios (%) 51.7344.8157.6121.79-19.88
Price / BV (X) 7.550.009.5112.304.22
Price / Net Operating Revenue (X) 5.160.006.197.532.90
EarningsYield 0.030.000.040.020.03

After reviewing the key financial ratios for Emami Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 16.55. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.55, marking an increase of 2.05.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 16.55. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.55, marking an increase of 2.05.
  • For Cash EPS (Rs.), as of Mar 24, the value is 20.93. This value is within the healthy range. It has increased from 20.00 (Mar 23) to 20.93, marking an increase of 0.93.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.30. It has increased from 52.43 (Mar 23) to 56.30, marking an increase of 3.87.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.30. It has increased from 52.43 (Mar 23) to 56.30, marking an increase of 3.87.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 81.97. It has increased from 77.20 (Mar 23) to 81.97, marking an increase of 4.77.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 22.83. This value is within the healthy range. It has increased from 21.12 (Mar 23) to 22.83, marking an increase of 1.71.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 18.57. This value is within the healthy range. It has increased from 15.51 (Mar 23) to 18.57, marking an increase of 3.06.
  • For PBT / Share (Rs.), as of Mar 24, the value is 18.20. This value is within the healthy range. It has increased from 15.35 (Mar 23) to 18.20, marking an increase of 2.85.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 16.67. This value is within the healthy range. It has increased from 14.39 (Mar 23) to 16.67, marking an increase of 2.28.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 16.58. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.58, marking an increase of 2.08.
  • For PBDIT Margin (%), as of Mar 24, the value is 27.84. This value is within the healthy range. It has increased from 27.35 (Mar 23) to 27.84, marking an increase of 0.49.
  • For PBIT Margin (%), as of Mar 24, the value is 22.64. This value exceeds the healthy maximum of 20. It has increased from 20.09 (Mar 23) to 22.64, marking an increase of 2.55.
  • For PBT Margin (%), as of Mar 24, the value is 22.20. This value is within the healthy range. It has increased from 19.87 (Mar 23) to 22.20, marking an increase of 2.33.
  • For Net Profit Margin (%), as of Mar 24, the value is 20.34. This value exceeds the healthy maximum of 10. It has increased from 18.64 (Mar 23) to 20.34, marking an increase of 1.70.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 20.22. This value exceeds the healthy maximum of 20. It has increased from 18.77 (Mar 23) to 20.22, marking an increase of 1.45.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 29.57. This value is within the healthy range. It has increased from 27.77 (Mar 23) to 29.57, marking an increase of 1.80.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 32.14. This value is within the healthy range. It has increased from 28.68 (Mar 23) to 32.14, marking an increase of 3.46.
  • For Return On Assets (%), as of Mar 24, the value is 22.06. This value is within the healthy range. It has increased from 20.56 (Mar 23) to 22.06, marking an increase of 1.50.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has increased from 1.00 (Mar 23) to 1.12, marking an increase of 0.12.
  • For Current Ratio (X), as of Mar 24, the value is 1.87. This value is within the healthy range. It has increased from 1.78 (Mar 23) to 1.87, marking an increase of 0.09.
  • For Quick Ratio (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 1.32 (Mar 23) to 1.44, marking an increase of 0.12.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.36. This value is below the healthy minimum of 4. It has decreased from 2.43 (Mar 23) to 2.36, marking a decrease of 0.07.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 48.26. This value is within the healthy range. It has decreased from 55.18 (Mar 23) to 48.26, marking a decrease of 6.92.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 38.39. This value is within the healthy range. It has decreased from 39.79 (Mar 23) to 38.39, marking a decrease of 1.40.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 51.74. This value is within the healthy range. It has increased from 44.82 (Mar 23) to 51.74, marking an increase of 6.92.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 61.61. This value is within the healthy range. It has increased from 60.21 (Mar 23) to 61.61, marking an increase of 1.40.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 99.86. This value is within the healthy range. It has decreased from 126.05 (Mar 23) to 99.86, marking a decrease of 26.19.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 74.54. This value is within the healthy range. It has decreased from 86.90 (Mar 23) to 74.54, marking a decrease of 12.36.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 18,339.38. It has increased from 0.00 (Mar 23) to 18,339.38, marking an increase of 18,339.38.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.13. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.13, marking an increase of 5.13.
  • For EV / EBITDA (X), as of Mar 24, the value is 18.41. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 23) to 18.41, marking an increase of 18.41.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.16, marking an increase of 5.16.
  • For Retention Ratios (%), as of Mar 24, the value is 51.73. This value is within the healthy range. It has increased from 44.81 (Mar 23) to 51.73, marking an increase of 6.92.
  • For Price / BV (X), as of Mar 24, the value is 7.55. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 7.55, marking an increase of 7.55.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.16, marking an increase of 5.16.
  • For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.03, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Emami Ltd as of May 12, 2025 is: 513.51

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 12, 2025, Emami Ltd is Overvalued by 19.00% compared to the current share price 634.00

Intrinsic Value of Emami Ltd as of May 12, 2025 is: 576.03

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 12, 2025, Emami Ltd is Overvalued by 9.14% compared to the current share price 634.00

Last 5 Year EPS CAGR: 12.17%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 29.42%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 11.00, which is a positive sign.
  3. The company has higher reserves (1,769.00 cr) compared to borrowings (201.62 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (2.15 cr) and profit (540.15 cr) over the years.
  1. The stock has a high average Cash Conversion Cycle of 7.58, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emami Ltd:
    1. Net Profit Margin: 20.34%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 32.14% (Industry Average ROCE: 36.03%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 29.57% (Industry Average ROE: 22.75%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 74.54
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.44
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 35.1 (Industry average Stock P/E: 41.02)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.02
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Emami Ltd. is a Public Limited Listed company incorporated on 11/03/1983 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L63993WB1983PLC036030 and registration number is 036030. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 2921.57 Cr. and Equity Capital is Rs. 43.65 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Personal CareEmami Tower, 687, Anandapur, Kolkata West Bengal 700107investors@emamigroup.com
http://www.emamiltd.in
Management
NamePosition Held
Mr. R S AgarwalChairman Emeritus
Mr. R S GoenkaNon Executive Chairman
Mr. Harsha V AgarwalVice Chairman & Mng.Director
Mr. Mohan GoenkaVice Chairman & Whole Time Dir
Mr. Sushil K GoenkaWhole Time Director
Mrs. Priti A SurekaWhole Time Director
Mr. Prashant GoenkaWhole Time Director
Mr. Aditya V AgarwalNon Executive Director
Mr. C K DhanukaIndependent Director
Ms. Mamta BinaniIndependent Director
Mr. Rajiv KhaitanIndependent Director
Ms. Avani V DavdaIndependent Director
Mr. Anjan ChatterjeeIndependent Director
Mr. Anjani Kumar AgrawalIndependent Director
Mr. Debabrata SarkarIndependent Director
Mr. Anand RathiIndependent Director

FAQ

What is the intrinsic value of Emami Ltd?

Emami Ltd's intrinsic value (as of 12 May 2025) is ₹513.51 — 19.00% lower the current market price of 634.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 27,661 Cr. market cap, FY2025-2026 high/low of ₹860/467, reserves of 2,585 Cr, and liabilities of 3,594 Cr.

What is the Market Cap of Emami Ltd?

The Market Cap of Emami Ltd is 27,661 Cr..

What is the current Stock Price of Emami Ltd as on 12 May 2025?

The current stock price of Emami Ltd as on 12 May 2025 is 634.

What is the High / Low of Emami Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Emami Ltd stocks is ₹860/467.

What is the Stock P/E of Emami Ltd?

The Stock P/E of Emami Ltd is 35.1.

What is the Book Value of Emami Ltd?

The Book Value of Emami Ltd is 60.2.

What is the Dividend Yield of Emami Ltd?

The Dividend Yield of Emami Ltd is 1.26 %.

What is the ROCE of Emami Ltd?

The ROCE of Emami Ltd is 31.7 %.

What is the ROE of Emami Ltd?

The ROE of Emami Ltd is 30.0 %.

What is the Face Value of Emami Ltd?

The Face Value of Emami Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Emami Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE